search results for 
Logo

Earnings per share

Adjusted for the special effects of the mark-to-market accounting of the Mandatory Exchangeable Bonds (MEB) and the Contingent Value Rights (CVR) relating to the acquisition of APP Pharmaceuticals, the Fresenius Group achieved earnings per share of €4.73 in 2011 – an increase of 16%. Further details on earnings and information on earnings per share can be found in the Management Report and in the Notes.

KEY DATA OF THE FRESENIUS SHARE


  2011 2010 2009 2008 2007
1 Xetra closing prices on the Frankfurt Stock Exchange
2 Total number of ordinary shares multiplied by the respective Xetra year-end quotation on the Frankfurt Stock Exchange (ordinary and preference shares until January 28, 2011)
3 Proposal
4 Adjusted for special items resulting from changes in the market value (mark-to-market accounting) of the Mandatory Exchangeable Bonds (MEB) and Contingent Value Rights (CVR) in connection with the acquisition of APP Pharmaceuticals
5 Before special items relating to the APP acquisition
Number of shares 163,237,336 162,450,090 161,315,376 161,143,734 155,164,770
Stock exchange quotation1 in €          
High 75.62 67.59 43.76 60.87 63.35
Low 59.90 41.80 27.69 31.93 50.17
Year-end quotation 71.48 62.75 43.45 36.23 56.00
Market capitalization2 in million € 11,668 10,301 7,538 6,270 8,759
Total dividend distribution in million € 155.13 139.7 121.8 113.6 103.2
Dividend per share in € 0.953 0.86 0.75 0.70 0.66
Earnings per share in € 4.734 4.084 3.184 2.855 2.64

  2011 2010 2009 2008 2007
1 Xetra closing prices on the Frankfurt Stock Exchange
2 Total number of ordinary shares multiplied by the respective Xetra year-end quotation on the Frankfurt Stock Exchange (ordinary and preference shares until January 28, 2011)
3 Proposal
4 Adjusted for special items resulting from changes in the market value (mark-to-market accounting) of the Mandatory Exchangeable Bonds (MEB) and Contingent Value Rights (CVR) in connection with the acquisition of APP Pharmaceuticals
5 Before special items relating to the APP acquisition
Number of shares 163,237,336 162,450,090 161,315,376 161,143,734 155,164,770
Stock exchange quotation1 in €          
High 75.62 67.59 43.76 60.87 63.35
Low 59.90 41.80 27.69 31.93 50.17
Year-end quotation 71.48 62.75 43.45 36.23 56.00
Market capitalization2 in million € 11,668 10,301 7,538 6,270 8,759
Total dividend distribution in million € 155.13 139.7 121.8 113.6 103.2
Dividend per share in € 0.953 0.86 0.75 0.70 0.66
Earnings per share in € 4.734 4.084 3.184 2.855 2.64

Continue reading:
Analysts recommendations

QUICKFINDER

History

External related links

Tools

My Annual Report

Your page has been added successfully

Link für Popup